Pieter R. Cullis
72Patents
38h-index
83Co-inventors
91Inventor score
Filing activity: Jul 26, 1985 → Apr 6, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5595756A | Liposomal compositions for enhanced retention of bioactive agents | Human Necessities | 600 | Expired |
| US5976567A | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer | Human Necessities | 342 | Expired |
| US6815432B2 | Methods for encapsulating plasmids in lipid bilayers | Emerging Cross-Sectional Technologies | 303 | Expired |
| US5981501A | Methods for encapsulating plasmids in lipid bilayers | Emerging Cross-Sectional Technologies | 265 | Expired |
| US5885613A | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes | Emerging Cross-Sectional Technologies | 250 | Expired |
| US5008050A | Extrusion technique for producing unilamellar vesicles | Emerging Cross-Sectional Technologies | 239 | Expired |
| US6534484B1 | Methods for encapsulating plasmids in lipid bilayers | Emerging Cross-Sectional Technologies | 220 | Expired |
| US5204112A | Induction of asymmetry in vesicles | Emerging Cross-Sectional Technologies | 218 | Expired |
| US7422902B1 | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer | Emerging Cross-Sectional Technologies | 212 | Expired |
| US5077056A | Encapsulation of antineoplastic agents in liposomes | Emerging Cross-Sectional Technologies | 204 | Expired |
| US4880635A | Dehydrated liposomes | Human Necessities | 199 | Expired |
| US6858225B2 | Lipid-encapsulated polyanionic nucleic acid | Emerging Cross-Sectional Technologies | 185 | Expired |
| US6586410B1 | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer | Emerging Cross-Sectional Technologies | 185 | Expired |
| US5399331A | Method for protein-liposome coupling | Human Necessities | 162 | Expired |
| US5552155A | Fusogenic lipsomes and methods for making and using same | Emerging Cross-Sectional Technologies | 142 | Expired |
| US4975282A | Multilamellar liposomes having improved trapping efficiencies | Human Necessities | 126 | Expired |
| US6287591A | Charged therapeutic agents encapsulated in lipid particles containing four lipid components | Emerging Cross-Sectional Technologies | 125 | Expired |
| US5059421A | Preparation of targeted liposome systems of a defined size distribution | Human Necessities | 112 | Expired |
| US6835395B1 | Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles | Emerging Cross-Sectional Technologies | 110 | Expired |
| US5837282A | Ionophore-mediated liposome loading | Human Necessities | 103 | Expired |
| US5736155A | Encapsulation of antineoplastic agents in liposomes | Human Necessities | 101 | Expired |
| US7341738B2 | Lipid-encapsulated polyanionic nucleic acid | Emerging Cross-Sectional Technologies | 87 | Expired |
| US5785987A | Method for loading lipid vesicles | Human Necessities | 83 | Expired |
| US6759057B1 | Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs | Emerging Cross-Sectional Technologies | 80 | Expired |
| US5795589A | Liposomal antineoplastic agent compositions | Emerging Cross-Sectional Technologies | 80 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.